Vet school awarded grant for research into AMR

Jan 8, 2018

An award worth up to €2 million has been awarded to the University of Surrey’s School of Veterinary Medicine to fund research into emerging infectious diseases and antimicrobial resistance (AMR). The award was granted by the European Commission to help revolutionise veterinary, medical and environmental health research. It forms part of a landmark €90 million pan-European project between 41 acclaimed veterinary and medical laboratories. The study will see academics from the University of Surrey carry out ground-breaking research into the growing threat of food-borne zoonoses to the population’s health and the rise of AMR. “Recent zoonotic outbreaks such as avian influenza and the emergence of antibiotic resistance are perfect examples of why this research is urgently required,” explained Professor Roberto La Ragione, head of pathology and infectious diseases at the University of Surrey School of Veterinary Medicine. “Transmission of infectious diseases from animals to humans poses a significant threat to public health across the world and it is important that we act now to avoid its devastating effects.” Veterinary virology... ...

Read More

Veterinary/Animal Vaccines Market to Grow at 5.9% CAGR to 2022 Led by Europe – ReportsnReports

Nov 13, 2017

Veterinary/Animal Vaccines Market Size will reach $8.66 billion by 2022 from $6.50 billion in 2017 at a CAGR of 5.9% between (2017-2022) driven by the growth in livestock population and repeated breakouts of livestock diseases; increasing adoption of companion animals; rising incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new types of vaccines in the market. The key players in the veterinary vaccines market are Zoetis (US), Merck Animal Health (US), Elanco (US), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (US), and Virbac (France). Other notable players operating in this market include Vetoquinol (France), Hester (India), Hipra (Spain), IDT Biologika (Germany), China Animal Husbandry (China), Biogenesis Bago (Argentina), Tianjin Ringpu (China), and Jinyu Bio-technology (China). Geographically, Europe is the largest market for veterinary vaccines market, followed by North America but the APAC region is expected to witness the highest growth in the forecast period. This growth is primarily attributed to rising pet adoption, expansion of key vaccine players in... ...

Read More